Developments in depression in epilepsy: screening, diagnosis, and treatment

References

• Temkin O. The falling sickness: a history of epilepsy from the greeks to the beginnings of modern neurology. Baltimore, US: JHU Press; 1994.
   Google Scholar
• Jacoby A, Baker GA, Steen N, et al. The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study. Epilepsia. 1996;37:148–161.
   PubMed Web of Science ®Google Scholar
• Tellez-Zenteno JF, Patten SB, Jetté N, et al. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia. 2007;48:2336–2344.
   PubMed Web of Science ®Google Scholar
• Gilliam FG, Santos J, Vahle V, et al. Depression in epilepsy: ignoring clinical expression of neuronal network dysfunction? Epilepsia. 2004;45(Suppl 2):28–33.
   PubMedGoogle Scholar
• Adelow C, Andersson T, Ahlbom A, et al. Hospitalization for psychiatric disorders before and after onset of unprovoked seizures/epilepsy. Neurology 2012;78: 396–401. WNL.0b013e318245f461 [pii]. doi:10.1212/WNL.0b013e318245f461.
   PubMed Web of Science ®Google Scholar
• Hesdorffer DC, Ishihara L, Mynepalli L, et al. Epilepsy, suicidality, and psychiatric disorders: a bidirectional association. Ann Neurol 2012;72:184–191.
   PubMed Web of Science ®Google Scholar
• Kanner AM, Scharfman H, Jette N, et al. Epilepsy as a network disorder (1): what can we learn from other network disorders such as autistic spectrum disorder and mood disorders? Epilepsy Behav. 2017;77:106–113.
   PubMed Web of Science ®Google Scholar
• Sheline YI, Gado MH, Kraemer HC. Untreated depression and hippocampal volume loss. Am J Psychiatry. 2003;160:1516–1518.
   PubMed Web of Science ®Google Scholar
• Cotter DR, Pariante CM, Everall IP. Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res Bull. 2001;55:585–595.
   PubMed Web of Science ®Google Scholar
• Cotter D, Mackay D, Chana G, et al. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex. 2002;12:386–394.
   PubMed Web of Science ®Google Scholar
• Kanner AM. Can neurobiological pathogenic mechanisms of depression facilitate the development of seizure disorders? Lancet Neurol. 2012;11:1093–1102.
   PubMed Web of Science ®Google Scholar
• Mazarati A, Siddarth P, Baldwin RA, et al. Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine. Brain. 2008;131:2071–2083.
   PubMed Web of Science ®Google Scholar
• Jobe PC. Common pathogenic mechanisms between depression and epilepsy: an experimental perspective. Epilepsy Behav 2003;4(Suppl 3): S14–24. S152550500300221X [pii].
   PubMedGoogle Scholar
• Rajkowska G, Miguel-Hidalgo JJ, Wei J, et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry. 1999;45:1085–1098.
   PubMed Web of Science ®Google Scholar
• Kumar G, Couper A, O’Brien TJ, et al. The acceleration of amygdala kindling epileptogenesis by chronic low-dose corticosterone involves both mineralocorticoid and glucocorticoid receptors. Psychoneuroendocrinology. 2007;32:834–842.
   PubMed Web of Science ®Google Scholar
• Boylan LS, Flint LA, Labovitz DL, et al. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology. 2004;62:258–261.
   PubMed Web of Science ®Google Scholar
• Hitiris N, Mohanraj R, Norrie J, et al. Predictors of pharmacoresistant epilepsy. Epilepsy Res. 2007;75:192–196.
   PubMed Web of Science ®Google Scholar
• Nogueira MH, Yasuda CL, Coan AC, et al. Concurrent mood and anxiety disorders are associated with pharmacoresistant seizures in patients with MTLE. Epilepsia. 2017;58:1268–1276.
   PubMed Web of Science ®Google Scholar
• Cramer JA, Blum D, Reed M, et al. The influence of comorbid depression on seizure severity. Epilepsia 2003;44:1578–1584. 28403 [pii].
   PubMed Web of Science ®Google Scholar
• Mula M, von Oertzen TJ, Cock HR, et al. Clinical correlates of memory complaints during AED treatment. Acta Neurol Scand. 2016;134:368–373.
   PubMed Web of Science ®Google Scholar
• Gur-Ozmen S, Mula M, Agrawal N, et al. The effect of depression and side effects of antiepileptic drugs on injuries in patients with epilepsy. Eur J Neurol. 2017;24:1135–1139.
   PubMed Web of Science ®Google Scholar
• Kanner AM, Byrne R, Chicharro A, et al. A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy. Neurology. 2009;72:793–799.
   PubMed Web of Science ®Google Scholar
• Fazel S, Wolf A, Långström N, et al. Premature mortality in epilepsy and the role of psychiatric comorbidity: a total population study. Lancet. 2013;382:1646–1654.
   PubMed Web of Science ®Google Scholar
• Kerr MP, Mensah S, Besag F, et al. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia 2011;52:2133–2138.
   PubMed Web of Science ®Google Scholar
• Mula M, Cavalheiro E, Guekht A, et al. Educational needs of epileptologists regarding psychiatric comorbidities of the epilepsies: a descriptive quantitative survey. Epileptic Disord 2017. doi:10.1684/epd.2017.0915.
   PubMed Web of Science ®Google Scholar
• Malhi GS, Mann JJ. Depression. Lancet. 2018;392:2299–2312.
   PubMed Web of Science ®Google Scholar
• Siu AL, Bibbins-Domingo K, Grossman DC, et al. Screening for depression in adults: US preventive services task force recommendation statement. JAMA 2016;315:380–387.
   PubMed Web of Science ®Google Scholar
• Mula M. Neuropsychiatric Symptoms of Epilepsy. Berlin: Springer; 2016.
   Google Scholar
• Gill SJ, Lukmanji S, Fiest KM, et al. Depression screening tools in persons with epilepsy: A systematic review of validated tools. Epilepsia. 2017;58:695–705.
   PubMed Web of Science ®Google Scholar
• Gilliam FG, Barry JJ, Hermann BP, et al. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol. 2006;5:399–405.
   PubMed Web of Science ®Google Scholar
• Mula M, McGonigal A, Micoulaud-Franchi J-A, et al. Validation of rapid suicidality screening in epilepsy using the NDDIE. Epilepsia. 2016;57:949–955.
   PubMed Web of Science ®Google Scholar
• Mula M, Iudice A, La Neve A, et al. Validation of the hamilton rating scale for depression in adults with epilepsy. Epilepsy Behav. 2014;41:122–125.
   PubMed Web of Science ®Google Scholar
• Mula M. Depression in epilepsy. Curr Opin Neurol. 2017;30:180–186.
   PubMed Web of Science ®Google Scholar
• Wagner JL, Kellermann T, Mueller M, et al. Development and validation of the NDDI-E-Y: a screening tool for depressive symptoms in pediatric epilepsy. Epilepsia. 2016;57:1265–1270.
   PubMed Web of Science ®Google Scholar
• Birmaher B, Brent D, Bernet W, et al. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 2007;46:1503–1526. .
   PubMed Web of Science ®Google Scholar
• Reilly C, Atkinson P, Das KB, et al. Neurobehavioral comorbidities in children with active epilepsy: a population-based study. Pediatrics. 2014;133:e1586–1593.
   PubMed Web of Science ®Google Scholar
• Connolly SD, Bernstein GA, Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 2007;46:267–283.
   PubMed Web of Science ®Google Scholar
• Jones JE. Treating anxiety disorders in children and adolescents with epilepsy: what do we know? Epilepsy Behav. 2014;39:137–142.
   PubMed Web of Science ®Google Scholar
• Mendez MF, Cummings JL, Benson DF. Depression in epilepsy. Significance and phenomenology. Arch Neurol. 1986;43:766–770.
   PubMed Web of Science ®Google Scholar
• Kanner AM, Kozak AM, Frey M. The use of sertraline in patients with epilepsy: is it safe? Epilepsy Behav. 2000;1:100–105.
   PubMed Web of Science ®Google Scholar
• Mula M, Jauch R, Cavanna A, et al. Clinical and psychopathological definition of the interictal dysphoric disorder of epilepsy. Epilepsia. 2008;49:650–656.
   PubMed Web of Science ®Google Scholar
• Blanchet P, Frommer GP. Mood change preceding epileptic seizures. J Nerv Ment Dis. 1986;174:471–476.
   PubMed Web of Science ®Google Scholar
• Scaramelli A, Braga P, Avellanal A, et al. Prodromal symptoms in epileptic patients: clinical characterization of the pre-ictal phase. Seizure. 2009;18:246–250.
   PubMed Web of Science ®Google Scholar
• Gaitatzis A, Trimble MR, Sander JW. The psychiatric comorbidity of epilepsy. Acta Neurol Scand. 2004;110:207–220.
   PubMed Web of Science ®Google Scholar
• Mula M. Epilepsy-induced behavioral changes during the ictal phase. Epilepsy Behav. 2014;30:14–16.
   PubMed Web of Science ®Google Scholar
• Guimond A, Braun CMJ, Bélanger E, et al. Ictal fear depends on the cerebral laterality of the epileptic activity. Epileptic Disord. 2008;10:101–112.
   PubMed Web of Science ®Google Scholar
• Kanner AM, Soto A, Gross-Kanner H. Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy. Neurology. 2004;62:708–713.
   PubMed Web of Science ®Google Scholar
• Nishida T, Kudo T, Inoue Y, et al. Postictal mania versus postictal psychosis: differences in clinical features, epileptogenic zone, and brain functional changes during postictal period. Epilepsia. 2006;47:2104–2114.
   PubMed Web of Science ®Google Scholar
• Mula M. Topiramate and cognitive impairment: evidence and clinical implications. Ther Adv Drug Saf. 2012;3:279–289.
   PubMedGoogle Scholar
• Mula M, Sander JW. Negative effects of antiepileptic drugs on mood in patients with epilepsy. Drug Saf. 2007;30:555–567.
   PubMed Web of Science ®Google Scholar
• Trimble MR, Schmitz B. Forced normalization and alternative psychoses of epilepsy. Petersfield: Wrightson Biomedical Pub; 1998.
   Google Scholar
• Mula M, Trimble MR, Sander JW. Are psychiatric adverse events of antiepileptic drugs a unique entity? A study on topiramate and levetiracetam. Epilepsia. 2007;48:2322–2326.
   PubMed Web of Science ®Google Scholar
• Stephen LJ, Wishart A, Brodie MJ. Psychiatric side effects and antiepileptic drugs: observations from prospective audits. Epilepsy Behav. 2017;71:73–78.
   PubMed Web of Science ®Google Scholar
• Perucca P, Mula M. Antiepileptic drug effects on mood and behavior: molecular targets. Epilepsy Behav. 2013;26:440–449.
   PubMed Web of Science ®Google Scholar
• Mula M, Trimble MR, Lhatoo SD, et al. Topiramate and psychiatric adverse events in patients with epilepsy. Epilepsia. 2003;44:659–663.
   PubMed Web of Science ®Google Scholar
• White JR, Walczak TS, Leppik IE, et al. Discontinuation of levetiracetam because of behavioral side effects: a case-control study. Neurology. 2003;61:1218–1221.
   PubMed Web of Science ®Google Scholar
• Mula M, Hesdorffer DC, Trimble M, et al. The role of titration schedule of topiramate for the development of depression in patients with epilepsy. Epilepsia. 2009;50:1072–1076.
   PubMed Web of Science ®Google Scholar
• Macrodimitris S, Sherman EMS, Forde S, et al. Psychiatric outcomes of epilepsy surgery: a systematic review. Epilepsia. 2011;52:880–890.
   PubMed Web of Science ®Google Scholar
• Koch-Stoecker S, Schmitz B, Kanner AM. Treatment of postsurgical psychiatric complications. Epilepsia. 2013;54(Suppl 1):46–52.
   PubMedGoogle Scholar
• Malmgren K, Starmark JE, Ekstedt G, et al. Nonorganic and organic psychiatric disorders in patients after epilepsy surgery. Epilepsy Behav. 2002;3:67–75.
   PubMed Web of Science ®Google Scholar
• Bleuler E. Textbook of psychiatry. New York: The Macmillan Co; 1924.
   Google Scholar
• Blumer D. Dysphoric disorders and paroxysmal affects: recognition and treatment of epilepsy-related psychiatric disorders. Harv Rev Psychiatry. 2000;8:8–17.
   PubMed Web of Science ®Google Scholar
• Kanner AM, Barry JJ, Gilliam F, et al. Anxiety disorders, subsyndromic depressive episodes, and major depressive episodes: do they differ on their impact on the quality of life of patients with epilepsy? Epilepsia. 2010;51:1152–1158.
   PubMed Web of Science ®Google Scholar
• Mula M, Jauch R, Cavanna A, et al. Interictal dysphoric disorder and periictal dysphoric symptoms in patients with epilepsy. Epilepsia. 2010;51:1139–1145.
   PubMed Web of Science ®Google Scholar
• Krishnamoorthy ES. The evaluation of behavioral disturbances in epilepsy. Epilepsia. 2006;47(Suppl 2):3–8.
   PubMedGoogle Scholar
• Mintzer S, Lopez F. Comorbidity of ictal fear and panic disorder. Epilepsy Behav. 2002;3:330–337.
   PubMed Web of Science ®Google Scholar
• Blumer D. Psychiatric aspects of intractable epilepsy. Adv Exp Med Biol. 2002;497:133–147.
   PubMed Web of Science ®Google Scholar
• McLintock K, Foy R, House A, et al. A policy of universal screening for depression: caution needed. BMJ. 2016;353:i2174.
   PubMedGoogle Scholar
• Mula M. The pharmacological management of psychiatric comorbidities in patients with epilepsy. Pharmacol Res. 2016;107:147–153.
   PubMed Web of Science ®Google Scholar
• Barry JJ, Ettinger AB, Friel P, et al. Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav. 2008;13(Suppl 1):S1–29.
   PubMedGoogle Scholar
• Depression in adults: recognition and management | guidance and guidelines | NICE n.d.. [cited 2018 Oct 28]. Available from: https://www.nice.org.uk/guidance/cg90
   Google Scholar
• Depression in adults with a chronic physical health problem: recognition and management | guidance and guidelines | NICE n.d.. [cited 2018 Oct 28]. https://www.nice.org.uk/guidance/cg91
   Google Scholar
• Michaelis R, Tang V, Wagner JL, et al. Cochrane systematic review and meta-analysis of the impact of psychological treatments for people with epilepsy on health-related quality of life. Epilepsia. 2018;59:315–332.
   PubMed Web of Science ®Google Scholar
• Michaelis R, Tang V, Wagner JL, et al. Psychological treatments for people with epilepsy. Cochrane Database Syst Rev. 2017;10:CD012081.
   PubMedGoogle Scholar
• Michaelis R, Tang V, Goldstein LH, et al. Psychological treatments for adults and children with epilepsy: evidence-based recommendations by the International League Against Epilepsy Psychology Task Force. Epilepsia 2018;59:1282–1302.
   PubMed Web of Science ®Google Scholar
• Maguire MJ, Weston J, Singh J, et al. Antidepressants for people with epilepsy and depression. Cochrane Database Syst Rev. 2014;CD010682. DOI:10.1002/14651858.CD010682.pub2
   PubMed Web of Science ®Google Scholar
• Robertson MM, Trimble MR. The treatment of depression in patients with epilepsy. A double-blind trial. J Affect Disord. 1985;9:127–136.
   PubMed Web of Science ®Google Scholar
• Peng W-F, Wang X, Hong Z, et al. The anti-depression effect of Xylaria nigripes in patients with epilepsy: A multicenter randomized double-blind study. Seizure. 2015;29:26–33.
   PubMed Web of Science ®Google Scholar
• Thomé-Souza MS, Kuczynski E, Valente KD. Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression. Epilepsy Behav. 2007;10:417–425.
   PubMed Web of Science ®Google Scholar
• Hovorka J, Herman E, Nemcová I. Treatment of interictal depression with citalopram in patients with epilepsy. Epilepsy Behav. 2000;1:444–447.
   PubMed Web of Science ®Google Scholar
• Specchio LM, Iudice A, Specchio N, et al. Citalopram as treatment of depression in patients with epilepsy. Clin Neuropharmacol. 2004;27:133–136.
   PubMed Web of Science ®Google Scholar
• Kühn KU, Quednow BB, Thiel M, et al. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy Behav. 2003;4:674–679.
   PubMed Web of Science ®Google Scholar
• Bhagwagar Z, Goodwin GM. Lamotrigine in the treatment of bipolar disorder. Expert Opin Pharmacother. 2005;6:1401–1408.
   PubMed Web of Science ®Google Scholar
• Bandelow B, Wedekind D, Leon T. Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention. Expert Rev Neurother. 2007;7:769–781.
   PubMedGoogle Scholar
• Stein DJ, Baldwin DS, Baldinetti F, et al. Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: a pooled analysis of 6 studies. Eur Neuropsychopharmacol. 2008;18:422–430.
   PubMed Web of Science ®Google Scholar
• Ettinger AB, Kustra RP, Hammer AE. Effect of lamotrigine on depressive symptoms in adult patients with epilepsy. Epilepsy Behav. 2007;10:148–154.
   PubMed Web of Science ®Google Scholar
• Biton V, Sackellares JC, Vuong A, et al. Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures. Neurology. 2005;65:1737–1743.
   PubMed Web of Science ®Google Scholar
• Fakhoury TA, Barry JJ, Mitchell Miller J, et al. Lamotrigine in patients with epilepsy and comorbid depressive symptoms. Epilepsy Behav. 2007;10:155–162.
   PubMed Web of Science ®Google Scholar
• Fakhoury TA, Miller JM, Hammer AE, et al. Effects of lamotrigine on mood in older adults with epilepsy and co-morbid depressive symptoms: an open-label, multicentre, prospective study. Drugs Aging. 2008;25:955–962.
   PubMed Web of Science ®Google Scholar
• Mazza M, Della Marca G, Di Nicola M, et al. Oxcarbazepine improves mood in patients with epilepsy. Epilepsy Behav. 2007;10:397–401.
   PubMed Web of Science ®Google Scholar
• Mula M. Anticonvulsants - antidepressants pharmacokinetic drug interactions: the role of the CYP450 system in psychopharmacology. Curr Drug Metab. 2008;9:730–737.
   PubMed Web of Science ®Google Scholar
• Alper K, Schwartz KA, Kolts RL, et al. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry 2007;62: 345–354. S0006-3223(06)01196-6 [pii]. doi:10.1016/j.biopsych.2006.09.023.
   PubMed Web of Science ®Google Scholar
• Steinert T, Fröscher W. Epileptic seizures under antidepressive drug treatment: systematic review. Pharmacopsychiatry. 2018;51:121–135.
   PubMed Web of Science ®Google Scholar